Gland Pharma share price
You have to be logged in to add this to Watchlist.Gland Pharma is trading -0.78% lower at Rs 1,978.30 as compared to its last closing price. Gland Pharma has been trading in the price range of 2,028.25 & 1,935.30. Gland Pharma has given 3.65% in this year & -1.82% in the last 5 days.
Gland Pharma has TTM P/E ratio 39.34 as compared to the sector P/E of 31.07.There are 11 analysts who have initiated coverage on Gland Pharma. There are 4 analysts who have given it a strong buy rating & 2 analysts have given it a buy rating. 1 analysts have given the stock a sell rating.
The company posted a net profit of 192.42 Crores in its last quarter.
Listed peers of Gland Pharma include Biocon (0.27%), Glenmark Pharmaceuticals (-0.76%), Gland Pharma (-0.78%) etc.
Gland Pharma has a 51.83% promoter holding & 48.17% public holding.The Mutual Fund holding in Gland Pharma was at 1.29% in 30 Jun 2024. The MF holding has increased from the last quarter. The FII holding in Gland Pharma was at 6.88% in 30 Jun 2024. The FII holding has increased from the last quarter.
Gland Pharma share price range
|
| ||||
|
| ||||
Gland Pharma share Key Metrics
| Market Cap ( ₹ Cr.) | 32,863.85 | ||||||||||||||||||
|
|
Technical Trends
Long TermConsiders price movement over the last 6 months
Short TermConsiders price movement over the last 1-2 weeks
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Gland Pharma Corporate actions
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
| 06-Aug-24 | Quarterly Results |
| 22-May-24 | Audited Results & Final Dividend |
| 14-Feb-24 | Quarterly Results |
| 06-Nov-23 | Quarterly Results |
| 07-Aug-23 | Quarterly Results |
| 18-May-23 | Audited Results & A.G.M. |
| 23-Jan-23 | Quarterly Results |
| 26-Oct-22 | Quarterly Results |
| 20-Jul-22 | Quarterly Results |
| 19-May-22 | Audited Results |
| Meeting Date | Announcement On | Purpose |
| 20-Nov-23 | 19-Oct-23 | POM |
| 31-Aug-23 | 01-Aug-23 | AGM |
| 08-Mar-23 | 06-Feb-23 | POM |
| 30-Aug-22 | 19-May-22 | AGM |
| 22-Apr-22 | 21-Mar-22 | POM |
| 26-Aug-21 | 17-May-21 | AGM |
| 21-Sep-20 | 25-Aug-20 | AGM |
| 30-Sep-19 | 29-Aug-19 | AGM |
| Announcement On | Record Date | Ex-Dividend | Dividend Value |
| 22-May-24 | 16-Aug-24 | 16-Aug-24 | 20 |
FAQs about Gland Pharma share price
Gland Pharma is trading at 1978.30 as on Tue Jul 23 2024 10:23:34. This is -0.78% lower as compared to its previous closing price of 1993.90.
The market capitalization of Gland Pharma is 32592.83 Cr as on Tue Jul 23 2024 10:23:34.
The average broker rating on Gland Pharma is Hold. The breakup of analyst rating is given below -
- 4 analysts have given a strong buy rating
- 2 analysts have given a buy rating
- 1 analysts have given a hold rating
- 1 analysts have given a sell rating
- 3 analysts have given a strong sell rating
The 52 wk high for Gland Pharma is 2195.75 whereas the 52 wk low is 1172.05
Gland Pharma can be analyzed on the following key metrics -
- TTM P/E: 39.34
- Sector P/E: 31.07
- Dividend Yield: 1.00%
- D/E ratio: 0.04
Gland Pharma reported a net profit of 772.46 Cr in 2024.
Gland Pharma Quick Links
Gland Pharma Dividend Gland Pharma Bonus Gland Pharma News Gland Pharma AGM Gland Pharma Rights Gland Pharma Splits Gland Pharma Board Meetings Gland Pharma Key Metrics Gland Pharma Shareholdings Gland Pharma Profit Loss Gland Pharma Balance Sheet Gland Pharma Cashflow Gland Pharma Q1 Results Gland Pharma Q2 Results Gland Pharma Q3 Results Gland Pharma Q4 Results
Equity Quick Links
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks